HealthDay News — The U.S. Supreme Court said Tuesday that it will not hear Johnson & Johnson’s appeal over a $2 billion ruling in favor of women who said they developed ovarian cancer from using the company’s talc products.

The nation’s top court did not say why it rejected Johnson & Johnson’s appeal, the Associated Press reported.

A state court in Missouri initially awarded $4.7 billion to 22 women, but a state appeals court cut that to $2 billion and eliminated two of the plaintiffs.


Continue Reading

Johnson & Johnson claimed it was not treated fairly because it faced one trial involving 22 plaintiffs from 12 states and different backgrounds, the AP reported.

Associated Press Article